NR4A1 and neoplasm: No significant difference in the sensitivity to oxaliplatin was observed between ID1−/− and ID1−/−NR4A1−/− tumors (Fig. 8d–g and Supplementary Fig. 8f), indicating that ID1 mediated the effect of Nur77 and Nur77 acted upstream of ID1 in tumor growth regulation.